Target intelligence / Profile preview

Novel transcript, antisense to VIPR2

Molecular classification
lncRNA
01

Overview

This entry represents a long non-coding RNA gene designated "novel transcript, antisense to VIPR2" (Ensembl: ENSG00000287184), which is transcribed from a region opposite the coding sequence for the vasoactive intestinal peptide receptor 2 (VIPR2)[3]. lncRNAs in antisense orientation may regulate adjacent coding genes at the RNA level, but there is currently no direct evidence for this transcript having a recognized molecular function, disease association, or suitability as a drug target[3]. There is also no established abbreviation, aliases, or known interacting compounds. This indicates that ENSG00000287184 is unlikely to be a relevant target for pharmacological intervention or biomarker studies.

02

Biological functions

Other (potential regulation of VIPR2 gene via antisense transcription; specific roles uncharacterized)
03

Disease associations

Other (no direct evidence implicating this RNA in disease; any association is speculative and not established in authoritative sources)

Beyond the preview

Go deeper on Novel transcript, antisense to VIPR2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to VIPR2.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call